Linagliptin(668270-12-0)
- Name: Linagliptin
- Synonyms:BI 1356;BI 1356BS;Linagliptin;ONDERO;1H-Purine-2,6-dione,8-[(3R)-3-amino-1-piperidinyl]-7-(2-butynyl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-(9CI);1H-Purine-2,6-dione, 8-((3R)-3-amino-1-piperidinyl)-7-(2-butynyl)-3,7-dihydro-3-methyl-1-((4-methyl-2-quinazolinyl)methyl)-;(R)-8-(3-Amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione;Linagliptin;Tradjenta;
- Molecular Formula:C25H28N8O2
- Molecular Weight:472.55
- CAS Registry Number:668270-12-0
- EINECS:1308068-626-2
- Melting Point:202 °C
- Water Solubility:

Other Product
- 870093-23-5/Talarozole
- 2675-35-6/Sivifene
- 425386-60-3/Semagacestat
- 379231-04-6/Saracatinib
- 857402-23-4/Retaspimycin
- 944548-37-2/rafivirumab
- 869884-78-6/Radezolid
- 410528-02-8/palovarotene
- 686344-29-6/Otenabant
- 181816-48-8/Ombrabulin
- 180694-97-7/Mimopezil
- 868771-57-7/Melogliptin
- 78246-90-9/Cyclopropanecarbonylchloride, 3-(2-chloro-3,3,3-trifluoro-1-propen-1-yl)-2,2-dimethyl-
- 441798-33-0/macitentan
- 116412-83-0/4-Chloro-3,4'-DimethoxyBenzophenone
- 320367-13-3/Lixisenatide
- 668270-12-0/Linagliptin
- 96847-55-1/Levomilnacipran
- 327026-93-7/Lensiprazine
- 258818-34-7/Larazotide
- 223132-37-4/inolitazone
- 464213-10-3/Ibipinabant
- 944548-38-3/Foravirumab
- 892553-42-3/Etaracizumab
- 98819-76-2/Esreboxetine
- 355129-15-6/Eprotirome
- 488832-69-5/Elesclomol
- 834153-87-6/elagolix
- 480449-70-5/Edoxaban
- 867153-61-5/dulanermin